Everything you eat or drink affects your intestinal bacteria, and is likely to have an impact on your health. That is the finding of a large-scale study led by geneticist Cisca Wijmenga of the University Medical Center Groningen into the effect of food and medicine on the bacterial diversity in the human gut, which is published in the prestigious research journal Science of 29 April.
In this study researchers collected stool samples from more than 1100 people taking part in the LifeLines programme, which is monitoring the health of 165,000 residents of the Northern Netherlands. The samples were used to analyse the DNA of the bacteria and other organisms that live in the gut. In addition to stools, the study collected information on the participants’ diet, medicine-use and health.
This study is unique in that it focussed on a group of normal people whereas previous research was frequently focussed on patients with a specific illness. Further, the study covered an exceptionally large group of people and studied their gut DNA in detail. “Normally researchers only investigate one particular region of DNA in which different groups of bacteria can be distinguished,” Wijmenga explains. “We have mapped all the bacterial DNA to gain much more detailed information about bacteria types.”
This DNA analysis made it possible to examine which factors impact the diversity of the microbiome (the intestinal bacterial community unique to each of us). And that appears to be many. Wijmenga says, “You see, for example, the effect of diet in the gut.” People who regularly consume yogurt or buttermilk have a greater diversity of gut bacteria. Coffee and wine can increase the diversity as well, while whole milk or a high-calorie diet can decrease it.
“In total we found 60 dietary factors that influence the diversity. What these mean exactly is still hard to say,” explains UMCG researcher Alexandra Zhernakova, the first author of the Science article. “But there is a good correlation between diversity and health: greater diversity is better.”
Beyond diet, at least 19 different kinds of medicine – some of which are widely used –have an impact on microbiome diversity. An earlier study by Groningen researchers has shown that antacids decrease this diversity, while antibiotics and the diabetes drug metformin also have an effect. These are important findings Wijmenga stresses, “Disease often occurs as the result of many factors. Most of these factors, like your genes or your age, are not things you can change. But you can change the diversity of your microbiome through adapting your diet or medication. When we understand how this works, it will open up new possibilities.”
Recent research has demonstrated the importance of this. It is now possible to combat obesity through a ‘faecal transplantation’ in which the intestinal bacteria from a slender person are introduced into the gut of an obese patient. An appropriate diet or a specific medicine may produce the same effect on the microbiome.
Currently a lot of research is looking into the microbiome, but it often seems hard to reproduce. It is therefore striking that the results of a Belgian group published in the same issue of Science show about 80 percent agreement with those of the Groningen group. “The key is the way the research was done,” Wijmenga says. What was important was that the stool samples were frozen immediately by the participants themselves, and picked up by the researchers while still frozen. “When samples are sent in by post, as is often the case, you expose them to oxygen and high temperatures. These are conditions that some bacteria can’t survive in. These two Science articles have therefore set a new standard for future research in this field.”
This project was funded by grants from the Top Institute Food and Nutrition, the Netherlands Organization for Scientific Research, CardioVascular Research Nederland and the European Research Council, as well as institutional funding to the individual authors.
Read the article in Science: http://science.sciencemag.org/content/352/6285/565.full
Source: press release UMCG
Microglia, cellen in de hersenen die schade en rommel opruimen, ontwikkelen zich al veel eerder in de hersenen dan tot nu toe gedacht werd. UMCG-hoogleraar Moleculaire Neurobiologie Bart Eggen en zijn collega’s ontdekten dat deze cellen al vroeg in...
Onderzoekers van het UMCG hebben een nieuw mechanisme ontdekt dat verklaart waarom de longziekte PAH (pulmonale arteriële hypertensie) bij patiënten verergert. Ook deden zij onderzoek naar een nieuwe therapie die deze ziekte kan behandelen.
Two Covid-related research projects of the UMCG have been rewarded a subsidy from ZonMW. The first study focuses on Covid patients who were ill at home and have not been admitted to a hospital. The second study looks at general practitioner care...